Latest Stock Split Details
Key information about Brainstorm Cell Therapeutics Inc.'s most recent stock split
Split Date: 2024-10-01
Split Ratio: 1:15
Price Before Split: $0.22
Price After Split: $0.01
Impact of the Stock Split
Understanding what this means for shareholders
- The total value of your investment remains the same
- You now own 15.00 times fewer shares (a 1:15 ratio)
- The price per share is increased proportionally
Historical Stock Splits
A comprehensive history of Brainstorm Cell Therapeutics Inc.'s stock splits
| Date | Ratio | Is Reverse Split | Price Before Split | Price After Split |
|---|---|---|---|---|
| 2024-10-01 | 1:15 | Yes | $0.22 | $0.01 |
| 2014-09-16 | 1:15 | Yes | $0.28 | $0.02 |
| 2003-09-04 | 2:1 | No | N/A | N/A |
About Brainstorm Cell Therapeutics Inc.
Company overview and industry information
Brainstorm Cell Therapeutics Inc. (BCLI) operates in the Biotechnology industry. The recent 1-for-15 reverse stock split is part of the company's strategy to adjust its share price and potentially meet stock exchange listing requirements.
Biotechnology
Go to Brainstorm Cell Therapeutics Inc. Summary